Brown Shipley& Co Ltd Sells 1,053 Shares of Agilent Technologies, Inc. $A

Brown Shipley& Co Ltd cut its stake in shares of Agilent Technologies, Inc. (NYSE:A) by 4.2% in the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 23,727 shares of the medical research company’s stock after selling 1,053 shares during the period. Agilent Technologies comprises approximately 1.6% of Brown Shipley& Co Ltd’s investment portfolio, making the stock its 23rd biggest position. Brown Shipley& Co Ltd’s holdings in Agilent Technologies were worth $2,776,000 as of its most recent filing with the SEC.

Other hedge funds also recently modified their holdings of the company. Whipplewood Advisors LLC grew its position in Agilent Technologies by 286.2% during the 1st quarter. Whipplewood Advisors LLC now owns 251 shares of the medical research company’s stock worth $29,000 after acquiring an additional 186 shares during the last quarter. Sunbelt Securities Inc. boosted its stake in shares of Agilent Technologies by 640.0% during the fourth quarter. Sunbelt Securities Inc. now owns 222 shares of the medical research company’s stock valued at $30,000 after purchasing an additional 192 shares in the last quarter. Stone House Investment Management LLC bought a new stake in shares of Agilent Technologies during the first quarter worth about $30,000. Opal Wealth Advisors LLC acquired a new position in shares of Agilent Technologies in the first quarter valued at approximately $31,000. Finally, Wood Tarver Financial Group LLC acquired a new position in shares of Agilent Technologies in the fourth quarter valued at approximately $34,000.

Agilent Technologies Stock Performance

Shares of A opened at $118.9710 on Thursday. The company has a current ratio of 2.09, a quick ratio of 1.60 and a debt-to-equity ratio of 0.55. The stock has a market capitalization of $33.80 billion, a P/E ratio of 29.38, a price-to-earnings-growth ratio of 3.64 and a beta of 1.22. The firm’s fifty day simple moving average is $117.83 and its two-hundred day simple moving average is $117.87. Agilent Technologies, Inc. has a 12 month low of $96.43 and a 12 month high of $153.84.

Agilent Technologies (NYSE:A) last posted its quarterly earnings data on Wednesday, May 28th. The medical research company reported $1.31 earnings per share for the quarter, topping the consensus estimate of $1.26 by $0.05. The firm had revenue of $1.67 billion during the quarter, compared to analyst estimates of $1.63 billion. Agilent Technologies had a return on equity of 25.92% and a net margin of 17.59%.The business’s quarterly revenue was up 6.0% on a year-over-year basis. During the same period last year, the company posted $1.22 EPS. Agilent Technologies has set its FY 2025 guidance at 5.540-5.610 EPS. Q3 2025 guidance at 1.350-1.370 EPS. As a group, analysts predict that Agilent Technologies, Inc. will post 5.58 EPS for the current year.

Wall Street Analysts Forecast Growth

Several research firms recently commented on A. Robert W. Baird cut their target price on shares of Agilent Technologies from $159.00 to $140.00 and set an “outperform” rating on the stock in a research report on Thursday, May 22nd. JPMorgan Chase & Co. cut their price target on shares of Agilent Technologies from $160.00 to $155.00 and set an “overweight” rating on the stock in a report on Thursday, May 29th. Evercore ISI boosted their price objective on shares of Agilent Technologies from $125.00 to $130.00 and gave the stock an “in-line” rating in a research note on Tuesday, July 8th. Leerink Partners raised their target price on Agilent Technologies to $135.00 and gave the stock a “buy” rating in a research report on Friday, May 30th. Finally, Barclays upped their price target on Agilent Technologies from $115.00 to $125.00 and gave the company an “equal weight” rating in a research report on Tuesday, June 24th. Seven analysts have rated the stock with a Buy rating and six have given a Hold rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $139.77.

Insider Activity at Agilent Technologies

In other news, CEO Padraig Mcdonnell sold 1,508 shares of Agilent Technologies stock in a transaction on Tuesday, July 1st. The shares were sold at an average price of $117.44, for a total value of $177,099.52. Following the completion of the sale, the chief executive officer owned 37,448 shares in the company, valued at $4,397,893.12. The trade was a 3.87% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.